Integrated care vans with Kathleen Page
In this episode, Ben Scher talks to Dr Kathleen Page about her evaluation of an integrated care van that ran in Baltimore offering healthcare interventions and buprenorphine prescribing. Dr Page discu...
9 Touko 202426min
Smoking and abdominal obesity with Germán Carrasquilla
In this episode Rob Calder talks to Dr Germán Carrasquilla about his study assessing whether smoking cased increases in abdominal obesity or belly fat. They discuss the implications of this kind of fa...
2 Touko 202417min
Benzodiazepines and treatment with Adam Bakker, Michael Liebrenz and Alexander Smith
In this episode Ben Scher talks to Dr Adam Bakker, Professor Michael Liebrenz and Dr Alexander Smith about their commentary in response to a previous paper by Domzaridou and colleages (2023). They dis...
25 Huhti 202423min
Contingency management with Gabriela Khazanov, James, McKay and Richard Rawson
In this episode, Ben Scher talks to Dr Gabriela Khazanov, Professor James McKay and Professor Richard Rawson. They discuss what contingency management is and how effective it can be in treatment setti...
17 Huhti 202427min
Xylazine, heroin and drug markets with Caroline Copeland
In this episode Ben Scher talks to Dr Caroline Copeland about her work analysing drug death data to identify drug use trends, harms and to inform policy. Caroline talks about how xylazine first entere...
9 Huhti 202420min
Synthetic opioid production in Europe with Paul Griffiths
In this episode, Dr Elle Wadsworth talks to Paul Griffiths about synthetic drug production in Europe including the differences between lab-made substances and diverted medical drugs. They discuss orga...
4 Huhti 202433min
Gambling advertising with Philip Newall
In this episode, Rob Calder talks to Dr Philip Newall about how the gambling industry frames the evidence on gambling advertising. Philip talks about researching the kinds of bets that are commonly ad...
8 Helmi 202432min
